Blaze is a privately held biotechnology company dedicated to improving the lives of cancer patients, starting with kids undergoing brain cancer surgery.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $22.5M
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | Willamette... | willamette... |
| - | Keiretsu F... | keiretsufo... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.12.2013 | Series B | $9M | - |
| 22.02.2013 | Series A | $8.5M | - |
| 08.06.2012 | Series A | $5M | - |
Mentions in press and media 19
| Date | Title | Description | Source |
| 26.02.2019 | How scorpion venom helps improve brain cancer surgery in chi... | Blaze Bioscience’s “Tumor Paint” is a synthetic version of a peptide originally found in the Israeli... | geekwire.c... |
| 11.10.2017 | Seattle Biotech Blaze Bioscience Adds $16M for Clinical Tria... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Blaze Bioscience, a Seattle-based ... | xconomy.co... |
| 09.01.2014 | Avelas’ luminous mapping technology to guide breast cancer s... | Avalon Ventures led the round and new investors Torrey Pines Investment, WuXi AppTec and an unnamed ... | medcitynew... |
| 23.12.2013 | Deals of the Year: The top 28 venture capital investments we... | Venture capital investing in Washington state started out with a whimper in 2013, but it is ending w... | geekwire.c... |
| 03.12.2013 | Tumor paint startup Blaze Bioscience raises $9M to help surg... | Blaze Bioscience has raised $9 million in fresh funding from individual investors, money that the Se... | geekwire.c... |
| 03.12.2013 | Blaze Bioscience Raises $9M in Series B Financing | Blaze Bioscience, Inc., a Seattle, WA-based biotechnology company, raised $9m in Series B financing.... | finsmes.co... |
| 03.12.2013 | Imaging agent that ‘paints’ tumor cells for more precise rem... | In the video above, Blaze Bioscience’s scientific founder, Dr. James Olson, describes how the scorpi... | medcitynew... |
| 03.12.2013 | Tumor Paint helps doctors cut the cancers, not healthy tissu... | Jim Olson has spent far too many years explaining to parents why he removed a healthy part of their ... | venturebea... |
| 22.02.2013 | Blaze Bioscience Grabs $8.5M Series A | SEATTLE, WA, Biotechnology company dedicated to developing innovative products to improve the live... | vcnewsdail... |
| 22.02.2013 | Blaze Bioscience raises $8.5M to help surgeons pinpoint canc... | Jim Olson Seattle biotechnology startup Blaze Bioscience has raised $8.5 million to continue develo... | geekwire.c... |
Show more